EP3509585

TREATMENT OF SYMPTOMS RELATED TO NEURODEGENERATIVE DISORDERS THROUGH PHARMACOLOGICAL DERMAL ACTIVATION OF CRANIAL NERVES

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    5.9.2017
  • EP published:
    1.11.2023
  • EP application number:
    17849385.4
  • Max expiry date:
    4.9.2037
  • Title in English:
    TREATMENT OF SYMPTOMS RELATED TO NEURODEGENERATIVE DISORDERS THROUGH PHARMACOLOGICAL DERMAL ACTIVATION OF CRANIAL NERVES
  • Language of the patent:
    English

Timeline

Today
5.9.2017EP application
1.11.2023EP Publication

Owner

  • Name:
    Glia, LLC
  • Address:
    134 Saint Botolph Street, Boston, Massachusetts 02115-4819, US

Inventor

  • Name:
    CHANG, Wei-wei
  • Address:
    Boston, Massachusetts 02115, US
  • Name:
    SAWYER, Kenneth I.
  • Address:
    Cushing, Maine 04563, US

Priority

  • Number:
    201662384458 P
  • Date:
    7.9.2016
  • Country:
    US

Classification

  • Categories:
    A61K 31/352, A61P 25/00, A61K 31/57, A61K 9/00, A61K 31/164, A61K 31/473, A61K 31/565, A61K 31/568, A61K 31/573, A61K 45/06, A61P 21/02, A61P 25/16, A61P 25/28, A61P 27/02

Upload documents